Siemens AG
This article was originally published in The Gray Sheet
Executive Summary
Plans to fill on July 25 its first U.S. order for the Magnetom open magnetic resonance imaging system, which was placed by the UCLA Medical Center. The company has already received 20 American and 50 international orders for the device, approved March 23 by FDA. Siemens believes the Magnetom's "virtually unlimited patient access," "excellent price/performance ratio," and ability to perform "kinematic joint studies" will enable it to compete with the Toshiba and Hitachi open MRIs on the market. Magnetom's list price ranges from $875,000 to $950,000, depending on options
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.